Bibliographie (2530)
A WHO expert explains why she believes the rush for Covid-19 boosters is premature.
mardi, 10 août 2021 15:09 Écrit par Zouhair SouissiA WHO expert explains why she believes the rush for Covid-19 boosters is premature – STAT Commentary on Twitter Must read interview on rich nations rushing into booster doses Dr @Kate_L_OBrien by @HelenBranswell @statnews "We really have huge inequity right now in just getting primary doses to people. Does a third dose need to […]
The post A WHO expert explains why she believes the rush for Covid-19 boosters is premature. appeared first on Links Medicus.
Covid-19: How effective are vaccines against the delta variant?
mardi, 10 août 2021 15:09 Écrit par Zouhair SouissiCovid-19: How effective are vaccines against the delta variant? – The BMJ
The post Covid-19: How effective are vaccines against the delta variant? appeared first on Links Medicus.
Pediatric asthma: The REGAP consensus.
lundi, 09 août 2021 03:18 Écrit par Zouhair SouissiPediatric asthma: The REGAP consensus – Anales de Pediatría
The post Pediatric asthma: The REGAP consensus. appeared first on Links Medicus.
Case report: Systemic capillary leak syndrome after ChAdOx1 nCOV-19 (Oxford–AstraZeneca) vaccination.
lundi, 09 août 2021 03:17 Écrit par Zouhair SouissiSystemic capillary leak syndrome afer ChAdOx1 nCOV-19 (Oxford–AstraZeneca) vaccination – Canadian Medical Association Journal
The post Case report: Systemic capillary leak syndrome after ChAdOx1 nCOV-19 (Oxford–AstraZeneca) vaccination. appeared first on Links Medicus.
More data showing one dose of Pfizer vaccine may be enough for individuals who’ve had COVID.
lundi, 09 août 2021 03:17 Écrit par Zouhair SouissiCommentary: One Dose of Pfizer Vaccine May Be Enough for Folks Who’ve Had COVID – HealthDay Original Study: SARS-CoV-2 Antibody Responses in Infection-Naive or Previously Infected Individuals After 1 and 2 Doses of the BNT162b2 Vaccine – JAMA Network Open Related: Perspective | Is one vaccine dose enough if you’ve had COVID? What the science […]
The post More data showing one dose of Pfizer vaccine may be enough for individuals who’ve had COVID. appeared first on Links Medicus.
COVID vaccine boosters: the most important questions.
lundi, 09 août 2021 03:17 Écrit par Zouhair SouissiCOVID vaccine boosters: the most important questions – Nature Commentary on Twitter I agree with @nataliexdean: “We just don’t have clear evidence of enough of a loss of efficacy to change our focus or distract from the main goal, which is trying to get as many people first doses” as possible." https://t.co/FEKB4vg0Dz — Sanghyuk […]
The post COVID vaccine boosters: the most important questions. appeared first on Links Medicus.
CDC study showed a reduced risk of reinfection with SARS-CoV-2 after covid-19 vaccination.
lundi, 09 août 2021 03:17 Écrit par Zouhair SouissiReduced Risk of Reinfection with SARS-CoV-2 After COVID-19 Vaccination — Kentucky, May–June 2021 – CDC Morbidity and Mortality Weekly Report Commentaries on Twitter This is non randomized. The two biases are: 1. Behavior among those who got vaccinated likely different than those who don't 2. Likely those who didn't tested more aggressively I would […]
The post CDC study showed a reduced risk of reinfection with SARS-CoV-2 after covid-19 vaccination. appeared first on Links Medicus.
M-A: SARS-CoV-2 Setting-specific transmission rates – “Households showed the highest transmission rates, with a pooled secondary attack rates of 21.1%”.
lundi, 09 août 2021 03:17 Écrit par Zouhair SouissiSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Setting-specific Transmission Rates: A Systematic Review and Meta-analysis – Clinical Infectious Diseases Commentary on Twitter SARS-CoV-2 setting-specific transmission rates: a systematic review and meta-analysis Households highest transmission rates, pooled SAR~21.1%. Contacts at social events~5.9%. Workplaces~1.9%. Age gradient for transmission potential in h/hold context. https://t.co/m27kkDrTgy — Andrew Lee […]
The post M-A: SARS-CoV-2 Setting-specific transmission rates – “Households showed the highest transmission rates, with a pooled secondary attack rates of 21.1%”. appeared first on Links Medicus.
RCT: Safety and immunogenicity of heterologous vs. homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine.
lundi, 09 août 2021 03:17 Écrit par Zouhair SouissiSafety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial – The Lancet Invited commentary: Optimising SARS-CoV-2 vaccination schedules – The Lancet Related: Another study shows increased immune response with heterologous Oxford-AstraZeneca/mRNA vaccination (several articles on the subject) Commentary on Twitter […]
The post RCT: Safety and immunogenicity of heterologous vs. homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine. appeared first on Links Medicus.
Perspective: Does Treating Sleep Apnea With CPAP Improve Cardiovascular Outcomes or Lower Risk of Atrial Fibrillation? – “Despite numerous flawed observational studies suggesting an association between sleep apnea and cardiovascular outcomes including atr
lundi, 09 août 2021 01:42 Écrit par Zouhair SouissiDoes Treating Sleep Apnea With CPAP Improve Cardiovascular Outcomes or Lower Risk of Atrial Fibrillation? – The Skeptical Cardiologist Related: AHA Scientific Statement: Obstructive Sleep Apnea and Cardiovascular Disease. Non-sleepy Obstructive Sleep Apnea: To Treat or Not to Treat? Pro/Con Debate: Should Asymptomatic Patients with Moderate-to-severe OSA be Treated? Obstructive Sleep Apnea in Cardiovascular Disease: […]
The post Perspective: Does Treating Sleep Apnea With CPAP Improve Cardiovascular Outcomes or Lower Risk of Atrial Fibrillation? – “Despite numerous flawed observational studies suggesting an association between sleep apnea and cardiovascular outcomes including atrial fibrillation the gold standard, high-quality RCT data do not clearly show that treatment of sleep apnea with CPAP improves cardiovascular outcomes”. appeared first on Links Medicus.
